These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)]. Matsuda T, Seki T, Miura R, Ogawara M, Yokouchi M, Yamanouchi H. Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815 [No Abstract] [Full Text] [Related]
5. Elevated serum elastase and alpha-1-antitrypsin levels in hemolytic uremic syndrome. Kaplan BS, Mills M. Clin Nephrol; 1988 Oct; 30(4):193-6. PubMed ID: 3265082 [Abstract] [Full Text] [Related]
6. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo. Noda Y, Nakamura M, Sasaki M, Kosugi T. Auris Nasus Larynx; 1986 Oct; 13 Suppl 1():S75-9. PubMed ID: 2429647 [Abstract] [Full Text] [Related]
8. The study of local fibrinolysis in abortion. Ikeuchi M. Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1215-23. PubMed ID: 2411832 [Abstract] [Full Text] [Related]
9. Inhibitors of fibrinolysis in diabetic children, mothers, and their newborn. Ambrus CM, Ambrus JL, Courey N, Mosovich L, Bruck E, Allen J, Jung O, Mirand E, Niswander K. Am J Hematol; 1979 Jul; 7(3):245-54. PubMed ID: 94976 [Abstract] [Full Text] [Related]
19. Control of coagulation and fibrinolysis by plasma proteinase inhibitors. Travis J, Salvesen G. Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838 [Abstract] [Full Text] [Related]
20. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro. Louise CB, Obrig TG. Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301 [Abstract] [Full Text] [Related] Page: [Next] [New Search]